Target intelligence / Profile preview

Immune system via secreted cytokines

Molecular classification
Other
01

Overview

The immune system via secreted cytokines refers to the complex network of small signaling proteins that mediate and regulate immunity, inflammation, and hematopoiesis (StatPearls: https://www.ncbi.nlm.nih.gov/books/NBK538174/). Cytokines, including interleukins, interferons, and tumor necrosis factors, are secreted by various immune cells such as macrophages, T-cells, and B-cells to communicate and coordinate responses to pathogens or tissue damage (NCBI: https://www.ncbi.nlm.nih.gov/books/NBK542220/). In many diseases, dysregulation of these cytokines leads to chronic inflammation, tissue destruction, or autoimmune disorders (Nature Reviews Immunology: https://www.nature.com/articles/nri.2017.111). Therapeutic intervention often involves the use of biologics or small molecules designed to inhibit specific pro-inflammatory cytokines or their receptors to dampen overactive immune responses (PubMed: https://pubmed.ncbi.nlm.nih.gov/29403023/). This broad category encompasses numerous specific drug targets that are critical for managing conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel disease, though their use requires careful monitoring for immunosuppression-related side effects (NIH: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151640/).

Other names
Cytokine signaling pathwayCytokine-mediated immune responseImmune modulation via cytokines
02

Mechanism of action

Modulation of the immune system by neutralizing secreted cytokines, blocking their respective receptors, or inhibiting intracellular signaling pathways (e.g., JAK/STAT) to reduce or enhance immune activity (StatPearls: https://www.ncbi.nlm.nih.gov/books/NBK538174/).

03

Biological functions

Immune responseSignal transductionCell-to-cell communicationInflammationHematopoiesis
04

Disease associations

Autoimmune diseaseInflammationCancerInfectionCytokine release syndrome
05

Safety considerations

Increased risk of serious opportunistic infectionsMalignancy risk (e.g., lymphoma)Cytokine release syndrome (CRS)Immunogenicity and anti-drug antibodiesInjection site or infusion reactions
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6) levelsTumor Necrosis Factor-alpha (TNF-α) levelsC-reactive protein (CRP)Erythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Immune system via secreted cytokines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system via secreted cytokines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call